• Fri, March 3, 2023

by: WOPRAI

Ryan Lynch Maintained (TRIN) at Hold with Increased Target to $14 on, Mar 3rd, 2023

by: WOPRAI

Jennifer Liang Downgraded (TSLA) to Hold and Held Target at $196 on, Mar 3rd, 2023

by: WOPRAI

Jairam Nathan Maintained (TSLA) at Buy with Increased Target to $218 on, Mar 3rd, 2023

by: WOPRAI

Allison Poliniak Maintained (UPS) at Buy with Increased Target to $221 on, Mar 3rd, 2023

by: WOPRAI

Jonathan Yon Maintained (UHS) at Buy with Decreased Target to $153 on, Mar 3rd, 2023

by: WOPRAI

Kelly Crago Maintained (ULTA) at Hold with Increased Target to $530 on, Mar 3rd, 2023

by: WOPRAI

Clark Lampen Initiated (TTD) at Hold on, Mar 3rd, 2023

by: WOPRAI

Vincent Colicchio Maintained (BBSI) at Buy and Held Target at $26 on, Mar 3rd, 2023

by: WOPRAI

Brian Gong Upgraded (BILI) to Strong Buy and Held Target at $28 on, Mar 3rd, 2023

by: WOPRAI

Jason English Reiterated (BILI) at Strong Buy and Held Target at $35 on, Mar 3rd, 2023

by: WOPRAI

Thomas Singlehurst Maintained (BFAM) at Strong Buy with Increased Target to $95 on, Mar 3rd, 2023

by: WOPRAI

Joseph Feldman Maintained (BBY) at Hold with Decreased Target to $81 on, Mar 3rd, 2023

by: WOPRAI

Karen Short Maintained (BBY) at Hold with Decreased Target to $85 on, Mar 3rd, 2023

by: WOPRAI

Michael Baker Maintained (BBY) at Strong Buy with Decreased Target to $96 on, Mar 3rd, 2023

by: WOPRAI

Scot Ciccarelli Maintained (BBY) at Hold with Increased Target to $88 on, Mar 3rd, 2023

by: WOPRAI

Timothy O"Shea Maintained (BCSF) at Sell with Increased Target to $13 on, Mar 3rd, 2023

by: WOPRAI

Laura Chico Upgraded (ARDX) to Buy and Increased Target to $6 on, Mar 3rd, 2023

by: WOPRAI

Robert Simmons Upgraded (ASAN) to Strong Buy on, Mar 3rd, 2023

by: WOPRAI

Douglas Tsao Reiterated (ARGX) at Strong Buy and Held Target at $480 on, Mar 3rd, 2023

by: WOPRAI

Roy Buchanan Maintained (ARGX) at Buy with Increased Target to $448 on, Mar 3rd, 2023

by: WOPRAI

Thomas Smith Maintained (ARGX) at Buy with Increased Target to $435 on, Mar 3rd, 2023

by: WOPRAI

Tom White Maintained (CARG) at Hold with Increased Target to $18 on, Mar 3rd, 2023

by: WOPRAI

John Ivankoe Maintained (CAKE) at Hold with Increased Target to $38 on, Mar 3rd, 2023

by: WOPRAI

John Royall Upgraded (CASY) to Hold and Increased Target to $211 on, Mar 3rd, 2023

by: WOPRAI

Anthony Paolone Maintained (CBRE) at Hold with Increased Target to $89 on, Mar 3rd, 2023

by: WOPRAI

Hamed Khorsand Maintained (ASRT) at Strong Buy with Increased Target to $8 on, Mar 3rd, 2023

by: WOPRAI

Bruno Amorim Maintained (ASR) at Hold with Increased Target to $255 on, Mar 3rd, 2023

by: WOPRAI

John Vinh Maintained (AVGO) at Buy with Increased Target to $72 on, Mar 3rd, 2023

by: WOPRAI

Ross Seymore Maintained (AVGO) at Strong Buy with Increased Target to $68 on, Mar 3rd, 2023

by: WOPRAI

William Stein Maintained (AVGO) at Strong Buy with Increased Target to $70 on, Mar 3rd, 2023

by: WOPRAI

Christopher Rolland Maintained (AVGO) at Buy and Held Target at $69 on, Mar 3rd, 2023

by: WOPRAI

Aaron Rakers Maintained (AVGO) at Hold with Increased Target to $60 on, Mar 3rd, 2023

by: WOPRAI

Hans Mosesmann Reiterated (AVGO) at Strong Buy and Held Target at $78 on, Mar 3rd, 2023

by: WOPRAI

Ed Arce Maintained (ABUS) at Strong Buy and Held Target at $6 on, Mar 3rd, 2023

by: WOPRAI

Keay Nakae Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Mar 3rd, 2023

by: WOPRAI

Erik Woodring Maintained (AAPL) at Buy with Increased Target to $180 on, Mar 3rd, 2023

by: WOPRAI

Scott Berg Reiterated (BILL) at Strong Buy and Held Target at $200 on, Mar 3rd, 2023

by: WOPRAI

Seldon Clarke Maintained (BLDR) at Strong Buy with Increased Target to $97 on, Mar 3rd, 2023

by: WOPRAI

Alex Henderson Reiterated (ZS) at Strong Buy and Held Target at $210 on, Mar 3rd, 2023

by: WOPRAI

Andrew Nowinski Maintained (ZS) at Buy with Decreased Target to $156 on, Mar 3rd, 2023

by: WOPRAI

Keith Bachman Maintained (ZS) at Buy with Decreased Target to $133 on, Mar 3rd, 2023

by: WOPRAI

Brian Essex Maintained (ZS) at Hold with Increased Target to $129 on, Mar 3rd, 2023

by: WOPRAI

Jonathan Ruykhaver Maintained (ZS) at Hold with Decreased Target to $140 on, Mar 3rd, 2023

by: WOPRAI

Michael Walkley Maintained (ZS) at Strong Buy with Decreased Target to $155 on, Mar 3rd, 2023

by: WOPRAI

Peter Levine Maintained (ZS) at Buy with Decreased Target to $165 on, Mar 3rd, 2023

by: WOPRAI

Joseph Vafi Maintained (ZUO) at Strong Buy with Increased Target to $16 on, Mar 3rd, 2023

by: WOPRAI

Mark Delaney Reiterated (ACR) at Buy and Held Target at $14 on, Mar 3rd, 2023

by: WOPRAI

Mark Kelley Reiterated (ACVA) at Buy and Held Target at $14 on, Mar 3rd, 2023

Andrew Cooper Downgraded (CDNA) to Hold and Held Target at $24 on, Mar 3rd, 2023

Andrew Cooper of Raymond James, Downgraded "CareDx, Inc" (CDNA) to Hold and Held Target at $24 on, Mar 3rd, 2023.

Andrew has made no other calls on CDNA in the last 4 months.



There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew

  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, February 28th, 2023
  • Mason Carrico of "Stephens & Co." Reiterated at Buy and Held Target at $19 on, Tuesday, February 28th, 2023
  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, February 28th, 2023

Like: 👍